Map * Disclaimer
* Site Search *
Virtual Reality and Bio
much of this will move to http://ThePiedPiper.tripod.com/vr0001.htm
added 28 Oct 2000
Kurzweil: Rooting for the Machine
by Declan McCullagh
1:35 p.m. Nov. 3, 2000 PST
BETHESDA, Maryland -- Raymond Kurzweil doesn't merely predict that machine intelligence will surpass human brains by the end of the century. He's eagerly anticipating it.
In a Kurzweillian future, the world would become a very strange place, where converging advances in
nanotechnology, biotechnology and computer science combine to propel humanity to its next stage of evolution.
Why Bill Joy is Elitist, Myopic, and Wrong
October 30, 2000
Why the future doesn't need us.
Our most powerful 21st-century technologies - robotics, genetic engineering, and nanotech - are threatening to
make humans an endangered species.
By Bill Joy
Charles M. Lieber Department of Chemistry, Harvard University 12 Oxford Street, Cambridge, MA 02138
Packard BioScience, DOD, and Russian Genome Project are working on this, there also suppose to be one that IBM has been working
on. Check out my citations on Fungus and imagion what would happen if fungus is capable of incorporating itís self into the source code of
these chips or into the human DNA source code.
Motorola, Packard Instrument Co. and Argonne to develop advanced biochip technology
ARGONNE, Ill. (June 29, 1998) -- Rapid advances in medicine, health care and agriculture are expected from a joint-research project announced today byMotorola Inc.,Packard Instrument Company and the U.S. Department of Energy's Argonne National Laboratory.
July 11, 2000
Packard BioScience Announces Issuance of Key Biochip Production Patents July 11, 2000
Meriden, CT -- Packard BioScience Company (Nasdaq: PBSC), a worldwide leader in the life science tools and nuclear industries, announced today the issuance of US Patents 6,079,283 and 6,083,762 ,which together include 44 claims providing broad and fundamental coverage encompassing biochip production by transfer of liquids through non-contact dispensing.
Packard BioScience Announces Issuance of Key Biochip Production Patents
These patents cover methods and devices for aspirating liquids and dispensing nanovolume droplets
containing biomolecules such as DNA, proteins and cells. This non-contact droplet dispensing technology,
also known as "drop-on-demand" dispensing, is analogous to ink-jetting technology and enables the
inexpensive production of high-quality gene chips and protein chips.
Background Q & A Biochip Commercialization Project
Motorola Inc., Packard Instrument Co., Argonne National Laboratory
What is the project's goal?
The goal is to develop and commercialize a new technology that can decode the genetic structures of living
things thousands of times faster than existing technology. The technology uses biochips, robots and computers to automate the massively parallel detection of gene mutations and to simultaneously analyze the activity of thousands of genes in healthy and diseased cells and tissues.
Who are the partners and what special capabilities does each provide?
The partners are Motorola Inc., Packard Instrument Company and the U.S. Department of Energy's Argonne
Each brings special expertise and capabilities to the project.
The 19 inventions, which have been licensed exclusively to Motorola and Packard, are the result of more than $10 million in research support since 1994 by the US. Department of Energy, the Defense Advanced Research Projects Agency, the Russian Academy of Sciences, and the Russian Human Genome Program.
Sequencing Technologies abstracts from the DOE Human Genome Program Contractor-Grantee Workshop VI
November 9-13, 1997, Santa Fe, NM